Mutational burden and signatures in 4000 Japanese cancers provide insights into tumorigenesis and response to therapy-Reference-Cited by-同舟云学术

Mutational burden and signatures in 4000 Japanese cancers provide insights into tumorigenesis and response to therapy

Published:2019-06-24 Issue:8 Volume:110 Page:2620-2628
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Hatakeyama Keiichi¹^ORCID,Nagashima Takeshi²³,Ohshima Keiichi¹,Ohnami Sumiko²,Ohnami Shumpei²,Shimoda Yuji²³,Serizawa Masakuni⁴,Maruyama Koji⁵,Naruoka Akane⁴^ORCID,Akiyama Yasuto⁶,Urakami Kenichi²,Kusuhara Masatoshi⁴⁷,Mochizuki Tohru¹,Yamaguchi Ken⁸

Affiliation:

1. Medical Genetics Division Shizuoka Cancer Center Research Institute Nagaizumi Japan

2. Cancer Diagnostics Research Division Shizuoka Cancer Center Research Institute Nagaizumi Japan

3. Corporate Project Office SRL Inc. Tokyo Japan

4. Drug Discovery and Development Division Shizuoka Cancer Center Research Institute Nagaizumi Japan

5. Experimental Animal Facility Shizuoka Cancer Center Research Institute Nagaizumi Japan

6. Immunotherapy Division Shizuoka Cancer Center Research Institute Nagaizumi Japan

7. Regional Resource Division Shizuoka Cancer Center Research Institute Nagaizumi Japan

8. Shizuoka Cancer Center Nagaizumi Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14087

Reference47 articles.

1. Signatures of mutational processes in human cancer

2. Hypermutation in human cancer genomes: footprints and mechanisms

3. Tumor Mutational Burden and Response Rate to PD-1 Inhibition

4. Mutational Processes Molding the Genomes of 21 Breast Cancers

5. COSMIC: exploring the world's knowledge of somatic mutations in human cancer

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker;Discover Oncology;2024-08-01

2. Characteristics of the immune environment in prostate cancer as an adjunct to immunotherapy;Health Science Reports;2024-07

3. The tumor immune microenvironment in pancreatic cancer and its potential in the identification of immunotherapy biomarkers;Expert Review of Molecular Diagnostics;2023-11-10

4. Pyroptosis‐related gene signatures are associated with prognosis and tumor microenvironment infiltration in head and neck cancer;Health Science Reports;2023-10

5. Impact of somatic mutations and transcriptomic alterations on cancer aneuploidy;Biomedical Research;2023-09-27